Sweden's liberal-conservative government has announced details of the final elements of its comprehensive pharmacy reform program, involving the shift from a state monopoly in the retailing of prescription and over-the-counter drugs to a largely privatized and deregulated system by the end of this year. Some medicines, such as aspirin, will be available outside pharmacies while pharmacists, who are currently graded as state-employed clerical staff, are granted flexible terms to take over the ownership of their stores. Big chains will also be encouraged, with 900 outlets - half of the country's total - offered for sale in packages of up to 20 pharmacies.
The government, a coalition of the libertarian-conservative Moderate party, the Christian Democrats and the Liberal People's Party, hopes that drug prices will be made more competitive. Pharmacies will be allowed to negotiate discounts with branded and generic drugmakers, while OTC products are already subject to free pricing.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze